quetiapine
Seroquel (quetiapine) is an atypical antipsychotic used for schizophrenia, manic and depressive episodes of bipolar I disorder, and as add-on treatment in major depressive disorder. It modulates dopamine and serotonin receptors, calming overactive signaling in mood and thought circuits.
This page is based on FDA prescribing information for quetiapine, cross-checked with MedlinePlus; the mechanism is explained in plain language, and analogies are used only where they stay accurate.
How it works
Explains what the medicine does in the body, not dosing, side effects, or safety.
An analogy
Think of the brain's thought and mood circuits as a busy intersection. In schizophrenia and bipolar disorder, too many cars — dopamine and serotonin signals — try to go through at once, causing chaos. Quetiapine acts like a traffic controller, easing the flow at both the dopamine and serotonin lights so the intersection runs more smoothly.
In simple terms
Quetiapine is an atypical antipsychotic that works on several chemical messengers in the brain, especially dopamine and serotonin. In conditions like schizophrenia, dopamine signaling becomes overactive in certain brain circuits, leading to hallucinations and disorganized thinking. Quetiapine blocks dopamine D2 receptors and serotonin 5-HT2A receptors, reducing that overactivity. It also has a strong effect on histamine receptors, which is why it can cause sleepiness. In bipolar depression, its metabolite norquetiapine adds a norepinephrine reuptake-blocking effect that helps lift mood. The combination of these actions makes quetiapine useful across several mood and psychotic disorders.
In depth
Quetiapine and its active metabolite norquetiapine together display a broad receptor profile: quetiapine antagonizes dopamine D2 and serotonin 5-HT2A receptors (contributing to antipsychotic and mood-stabilizing effects), while norquetiapine potently inhibits the norepinephrine transporter (NET), adding antidepressant activity. Both compounds have high affinity for histamine H1 receptors (sedation) and alpha-1 adrenergic receptors (orthostatic hypotension), moderate affinity for 5-HT1A receptors (partial agonism), and low affinity for muscarinic receptors. Quetiapine's relatively low D2 occupancy at therapeutic doses places it in the "fast-off" atypical antipsychotic category, which is thought to reduce extrapyramidal side effects while maintaining efficacy through multi-receptor modulation.
See it in motion
A schematic animation of the mechanism — simplified for clarity, not drawn to scale.
How quetiapine and its metabolite norquetiapine act across dopamine, serotonin and noradrenaline
- Quetiapine blocks dopamine D2 receptors and serotonin 5-HT2A receptors, reducing that overactivity.
- It also has a strong effect on histamine receptors, which is why it can cause sleepiness.
- In bipolar depression, its metabolite norquetiapine adds a norepinephrine reuptake-blocking effect that helps lift mood.
- Quetiapine's relatively low D2 occupancy at therapeutic doses places it in the "fast-off" atypical antipsychotic category, which is thought to reduce extrapyramidal side effects while maintaining efficacy through multi-receptor modulation.
Target: Dopamine D2 and serotonin 5-HT2A receptors
Overactivity of dopamine D2 signaling is linked to psychotic symptoms; serotonin 5-HT2A overstimulation contributes to mood dysregulation. Quetiapine blocks both, restoring balance in thought and mood circuits.
Approved uses
Approved uses differ by country and change over time. Always follow your local prescribing information.
Approved uses in United States
FDA- Treatment of schizophrenia
- Acute treatment of manic episodes associated with bipolar I disorder, as monotherapy and as adjunct to lithium or divalproex
- Monotherapy for acute treatment of depressive episodes associated with bipolar disorder
- Maintenance treatment of bipolar I disorder as adjunct to lithium or divalproex
Approved uses in United States
MedlinePlus- Treatment of schizophrenia, bipolar disorder, and major depressive disorder
Official sources
The statements on this page trace back to these records.
- U.S. Food and Drug Administration: quetiapine prescribing information
U.S. Food and Drug Administration
- MedlinePlus: quetiapine
MedlinePlus, U.S. National Library of Medicine
This page explains how the medicine works — it isn’t the patient leaflet. For anything that applies to you, read the leaflet that came with your medicine or ask your pharmacist.
MedUnfold provides educational content and is not medical advice. Always follow your local prescribing information and healthcare professional.